Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate

    • Product Name: tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
    • Chemical Name (IUPAC): tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
    • CAS No.: 1374852-50-2
    • Chemical Formula: C30H34FN1O4
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 133558
    Iupac Name tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
    Molecular Formula C31H36FNO4
    Molecular Weight 505.62 g/mol
    Appearance White to off-white solid
    Smiles CC(C)(C)OC(=O)CC(CO)CC(CO)C=Cc1cnc2cc(c(cc2c1)C3CC3)c4ccc(F)cc4
    Cas Number 1243402-47-2
    Stereochemistry (3R,5S,E)
    Solubility Soluble in DMSO, Methanol
    Chemical Class Quinoline-based heptenoate

    As an accredited tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 1-gram amber glass vial labeled with the chemical name, structure, batch number, and safety information, sealed for protection.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Securely packs tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate in sealed, labeled drums for safe transit.
    Shipping The shipping of tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate requires secure, leak-proof packaging, temperature control if necessary, and compliance with chemical transport regulations. Appropriate labeling and documentation ensure safe handling and prompt delivery, typically via certified chemical courier services. Delivery tracking and MSDS are provided.
    Storage Store tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate in a cool, dry, and well-ventilated area, protected from light and moisture. Keep the container tightly closed when not in use. Store at 2–8°C (refrigerated) and avoid exposure to incompatible substances such as oxidizing agents. Ensure proper chemical labeling and secure storage.
    Shelf Life Shelf life: Store tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate at -20°C, protected from light and moisture; stable for 2 years.
    Application of tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate

    Applications of tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate in Industrial Manufacturing

    As a specialized manufacturer, we supply tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate to a targeted selection of advanced industries. This page details verified industrial applications supported by real-world downstream manufacturing. Each scenario below details requirements from compliance to finished products within key pharmaceutical and chemical synthesis fields.

    1. Statin-Type Active Pharmaceutical Ingredient (API) Synthesis

    Downstream pharmaceutical manufacturers leverage this raw material as a crucial intermediate in the synthesis of next-generation HMG-CoA reductase inhibitor APIs, specifically for highly selective statins designed for hypercholesterolemia treatment. The compound’s protected tert-butyl ester form enables selective deprotection and side chain modification in multi-step API assembly, supporting precise stereochemical control. Its integration occurs mainly during late-stage side-chain introduction, impacting the pharmacodynamic properties of the end molecule. Formulators actively adjust the intermediate charge according to yield optimization targets and reaction scalability, all performed under strict regulatory frameworks and site GMP audits.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Chiral Building Block in Advanced Chemical Synthesis

    Advanced chemical producers in the fine chemical sector employ this molecule for its rich chiral centers and functionalized aromatic system. It supports asymmetric synthesis workflows in constructing complex heterocyclic compounds, especially where both tert-butyl ester protection and configuration retention are mandatory. Experienced process chemists introduce the material in stereocontrolled carbon–carbon coupling steps, promoting high yields in multi-step organic architectures. The enantioselectivity critical for downstream applications remains preserved through careful process control, typically under ISO-certified QC environments.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Pharmaceutical Reference Standards Manufacturing

    Certified producers of analytical reference substances utilize this compound for preparing highly pure reference standards needed in pharmaceutical quality control and regulatory registration. Laboratory-scale purification, crystallization, and characterization steps depend on the compound’s stereochemical clarity and consistent purity. These reference materials serve as calibration standards in chromatographic and spectrometric validation, supporting batch release of statin-type drugs globally. QC labs establish and maintain traceability records aligned with both pharmacopeial and regulatory expectations.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Analytical Method Development in Regulatory Laboratories

    Independent pharmaceutical regulators and contract labs employ this compound during analytical method development and validation, particularly in liquid chromatography and mass spectrometry applications for statin identification, related substances analysis, and impurity profiling. The known structure, stereochemistry, and defined purity levels make it an appropriate matrix for system suitability tests and resolution checks per current guidelines. The substance enables laboratories to standardize analytical results, assess precision, accuracy, and limit of quantitation parameters across international markets.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate: Experience Direct from the Factory Floor

    Seeing the Real World Through Chemicals

    Everyone working in industrial chemistry knows the value of hands-on experience when it comes to producing specialty intermediates. With years on the line formulating and scaling up advanced fluorinated compounds, our team spends each day measuring, synthesizing, and controlling quality so clients get genuine material—no detours, no unexplained variability. One intermediate customers increasingly request is tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate, which we produce under strictly managed, high-purity conditions. We thought it worthwhile to introduce a little “behind the factory gates” perspective on this unique molecule, straight from where it’s created, not from a warehouse shelf.

    What Sets Our tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate Apart?

    Chemists who handle rare or high-value pharmaceutical intermediates have no patience for unpredictability. In the synthesis of this dihydroxyhept-6-enoate, accuracy counts at every step. Our workforce, familiar with both campaign and continuous manufacturing, knows well how the geometry of the (3R,5S,E) configuration affects the downstream yield and how even a minor flaw in stereochemistry or fluorination can cost thousands of dollars downstream.

    We invest heavily in chiral resolution and analytical controls, not because a spec sheet told us to, but because the science of quinoline derivatives demands it. Fluorine placement and cyclopropyl substitution bring challenges during cyclization and hydrogenation—precisely those stages other vendors sometimes gloss over. Direct access to in-process analytical data ensures that our intermediates integrate seamlessly in customers’ syntheses, reducing both lost batches and lengthy troubleshooting that could shake the confidence of analytical chemists, process engineers, and management.

    Specifications That Matter—Experience Shows the Difference

    Clients come to us not simply searching for a set of numbers, but for material that fits into a real process. In the course of repeated scale-ups and kilo-lab milestones, we use chiral HPLC as a standard routine, not a premium extra. Spectral data, including proton NMR and 19F NMR, cross-check every batch for consistency. For a molecule of this complexity, mass spec integrity and purity verification via HPLC are not left to chance.

    Moisture and trace impurity content influence every downstream transformation. Our experience with sensitive fluorinated and cyclopropyl-containing molecules confirms that even tiny amounts of residual water or unrelated esters lead to inconvenience or even batch failures. With that in mind, we utilize stringent argon protection, moisture-scrubbing on all reagents, and regularly calibrate analytical equipment. Over time, this improves reproducibility across multiple lots. Analytical staff hand off reports directly to synthesis managers, encouraging a direct feedback loop only possible when research, production, and QA reside under one roof.

    Why Structure, Stereochemistry, and Purity Define Success

    tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate gains its value from its complexity. This isn't a straightforward alkane or commodity aromatic. The dihydroxyheptene backbone, stereocontrol at both the 3 and 5 positions, cyclopropyl ring tension, and the quinoline system's electron density together create an intermediate that will not forgive sloppiness. Each asymmetric carbon makes the final stages of synthesis sharper and more demanding.

    Practical evidence shows that controlling the formation of the E-olefin, especially in the presence of sensitive quinoline and fluorophenyl moieties, avoids a cascade of issues later. Our strategy involves selective hydrogenation and refined transition metal catalysis, two steps we consistently monitor through both benchtop TLC and scale-sensitive inline IR monitoring. We’ve learned these checks flag any shift in product ratio before it becomes a problem for downstream catalytic steps. Chemical manufacturing, at its best, anticipates issues with the rigors of real experience.

    Serving Advanced Pharmaceutical and Research Labs—No Detours

    Our customers use this product as a critical advanced intermediate for synthetic routes leading to novel pharmaceuticals—work requiring high integrity at every junction. Whether developing new cholesterol or lipid pathway inhibitors, or expanding the chemistry of functionalized quinolines, there are no shortcuts for accuracy. While outside labs sometimes see resold material lose activity or produce unexpected byproducts, working directly with the manufacturer gives assurance seldom matched by traders or repackagers.

    Solid, reproducible batches feed medicinal and scale-up chemists the reliability they need—something we’ve seen accelerate patent filings and grant applications. Direct engagement also enables real-world technical discussion rather than boilerplate product support, saving days or weeks otherwise lost clarifying details only true makers can address.

    Handling Sensitivity and Storage—Lessons from Production

    Learning the quirks and sensitivities of this intermediate didn’t emerge from textbooks—it took years monitoring warehouse conditions and actual material drift. Fluorinated, cyclopropyl-containing intermediates demand cool, dry, and inert storage. Too many labs discover degradation after transit, usually traced to porous packaging or storage near heat or bright light. We use thick, lined containers, in nitrogen atmospheres, not because codes dictate it but because results in long-haul shipping show it protects both chiral purity and overall recovery.

    Temperature fluctuations, particularly above 4°C, sometimes affect the subtle esters and primary hydroxyls, with even small increases in humidity triggering slow decomposition or color shifts. That creates headaches for researchers troubleshooting product performance, leading to uncertainty about experimental outcomes. Over time, we refined our storage recommendations not just on theoretical stability, but on a continuous stream of analytical data logged after deliveries and from customer feedback.

    Mastering Stereochemistry and Scale—Real-World Challenges and Solutions

    It’s easy to note “high chiral purity” on a website. The real challenge comes at the kilogram level, not just in gram-scale research. We’ve built a process where enantioselective catalyst loading, aqueous workup, and purification don’t drift batch to batch. With complex intermediates, even minor temperature spikes during workup shift optical rotation and reduce fit with downstream biochemistry. Through routine optimization and re-validation with every kilo-scale campaign, our team has wrung out most surprises in the process.

    Manufacturers who only offer this intermediate as a catalog repackage miss the demands of custom runs. We adjust solvents, vacuum rates, and crystallization conditions based on observed variances in precipitation, tackiness, and filterability. Customer feedback cycles into direct synthetic optimization, a loop that doesn’t function without continuous, real-world production. Scale-up chemists benefit from patterns learned through actual tens of kilos, not just isolated gram runs.

    Batches are documented with the same care whether one bottle or several drums leave the plant. This kind of discipline takes root only with full ownership of every operation from raw quinoline building blocks to finished tert-butyl ester. A factory with sightlines on every synthetic step gives direct insight that impersonal stock lists or third-party logistics never achieve.

    Comparing Alternatives—Why In-House Production Trumps Outsourced Material

    Chemists often ask what makes this intermediate different from other offerings, especially when facing price ranges or claims from resellers. One answer stays consistent: full control over process and quality translates to higher batches passing QA. While many resellers or trading companies provide off-the-shelf versions, these often arrive with inconsistent moisture levels, unknown synthesis histories, or incomplete batch documentation.

    Direct production means we track every synthetic decision, every purification tweak. We know when a supplier’s quinoline has a higher trace-metal content or if a recent lot’s chiral auxiliary veered slightly acidic or basic. That experience enables clients to ask about trace impurities, alternative salt forms, or custom handling—and get real answers instead of a “please wait while we check.”

    Third-party stock may be suitable for basic screening, but for preclinical or registered API routes, confidence stems from material made with traceability and open, immediate access to the team that synthesized, tested, and packaged it. This approach cuts surprises and gives clients faster paths through validation and tech transfer, since real manufacturing insight travels along with each shipment.

    Supporting Regulatory and Analytical Requirements

    As more researchers and pharmaceutical companies look to comply with global standards, the need for documentation and traceable provenance deepens. Internally, our operation aligns ISO, GMP, and environmental practices not through checklists, but by regular inspection and hands-on oversight at every batch stage. Audit trails for material receipt, batch genealogy, and analytical cross-checks all stand ready to give clarity when regulatory teams ask for supporting documentation.

    We compile and store electronic and hardcopy records on batch release, detailed spectral printouts, calibration logs, and stability reports. Decades in regulated supply chains taught us how to navigate both U.S. and emerging market requirements, and we deliver this insight with each intermediate shipped. Clients say the easy turn-around on C of A’s, impurity profiling, and deep-dive analytical detail reduces rework in compliance audits and tech transfer. The documentation serves scientists today and stands up to diligence from health authorities tomorrow.

    Supporting Innovation and Continuous Improvement

    Hands-on production involves ongoing review and process improvement. The best synthetic routes aren’t static; as new catalysts, greener reagents, or better filtration media come to market, we trial and validate them under actual production conditions. A feedback mechanism directly ties in the line chemist, QC bench, and the research team, allowing process improvements without unnecessary bureaucracy.

    Customer suggestions often lead to new salt forms, alternative protective group strategies, or scale optimizations. This openness shortens both development and lead times for pharmaceutical teams racing to file patents or scale up clinical supply. A factory-based team makes these refinements possible without the lag or confusion of long, indirect supply chains.

    Use Cases and Applications

    tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate stands at the junction of practical chemistry and innovation. Its role as a complex intermediate in pharmaceutical syntheses, particularly among programs targeting new cholesterol-lowering agents and other quinoline-derived drug candidates, has grown as more R&D groups push the limits of medicinal chemistry. Our factory supplies labs pursuing both established and innovative targets, delivering both standard and custom specifications as new research demands.

    Research groups share feedback about successful downstream transformations, particularly where control of stereochemistry and protection of the hydroxy groups enable more efficient lead generation and SAR work. Companies scaling from lead optimization to pilot and clinical scale appreciate the consistency that comes from direct manufacturer engagement, ranging from bulk batch lots to just-in-time small quantities. Lessons learned producing and handling advanced intermediates for global customers circle back to influence each new run, moving innovation forward one batch at a time.

    Environmental Stewardship and Safety at the Source

    Manufacturing specialty chemicals such as this intermediate requires more than technical know-how. It involves a direct commitment to safety, waste minimization, and environmental care. Our plant invests in closed-handling systems, solvent recycling, and effluent monitoring—not simply to check boxes, but to ensure a safer workspace for our team and a lower-impact product for downstream users.

    Careful segregation of fluorinated and basic waste, routine environmental testing, and rigorous staff training reflect everyday realities of working with advanced, sometimes reactive intermediates. These practices help companies worldwide meet their own sustainability and safety commitments by sourcing transparently and responsibly. With every drum or vial leaving our plant, we stand behind the product from both a technical and ethical standpoint—realities our clients recognize and respect.

    Building Trust and Enabling Collaboration

    Years of manufacturing and supplying tert-butyl (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate give us an appreciation for the challenges chemists and project managers face. Trust, in this industry, isn’t built by certificates or price lists; it comes from consistent delivery, transparent communication, and clear results. Our direct engagement on technical issues—whether that’s handling, storage, custom runs, or regulatory support—enables companies to take on more ambitious chemistry, safer scale-ups, and faster commercial launches.

    Many customers return for insight on related intermediates, share their goals for the next stage of testing, or even request new synthetic pathways. As a manufacturer rooted in real production and ongoing collaboration, our factory delivers more than material—we deliver shared experience, mutual understanding, and solutions forged from daily practice. Bringing advanced intermediates forward, factory to lab, remains both a technical and human achievement, and we remain proud to play a genuinely active role.